BioSpace News Archive

Business

Nomination of Dr. Kaushik Majumdar as GPI’s Interim Executive Director

The Global Phosphorus Institute (GPI) announced on June 16th 2022 the designation of Dr. Kaushik Majumdar as Interim Executive Director, with missions of operationalization of current Projects & Activities and further development of GPI.

July 18, 2022
·
2 min read
Policy

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie announced it has submitted a marketing authorization application to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

July 18, 2022
·
11 min read
Business

Tiziana Life Sciences Appoints Matthew W. Davis, MD, RPh as Chief Medical Officer and Acting Chief Scientific Officer

Tiziana Life Sciences Ltd. announces that it has appointed Matthew Davis, MD, RPh as its Chief Medical Officer and Acting Chief Scientific Officer, effective immediately.

July 18, 2022
·
3 min read
Business

Carl Zeiss Meditec and Precise Bio Announce Partnership in the Development and Commercialization of Tissue-Based Implants for Ophthalmology

Carl Zeiss Meditec and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, announced that the companies have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.

July 18, 2022
·
5 min read
Healthcare Analytical Testing Services Market: Increasing Analytical Testing Rate of Biosimilar and Biologics to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global healthcare analytical testing services market has gathered pace in its growth due to the enormous demand for research and development outsourcing.

July 18, 2022
·
5 min read
Business

Relief Therapeutics Announces that its Collaboration Partner has Resubmitted the ACER-001 (Sodium Phenylbutyrate) New Drug Application (NDA) to the FDA for the Treatment of Urea Cycle Disorders (UCDs)

RELIEF THERAPEUTICS Holding SA, announced that its collaboration partner, ACER Therapeutics, Inc., for ACER-001 for oral suspension for the treatment of patients with urea cycle disorders, has resubmitted its New Drug Application for ACER-001 to the U.S. Food and Drug Administration.

July 18, 2022
·
4 min read
Business

DaVita Inc. Schedules 2nd Quarter 2022 Investor Conference Call

DaVita Inc., announced that it will hold its quarterly conference call to discuss second quarter results on Monday, August 1, 2022, at 5:00 p.m. Eastern Time.

July 18, 2022
·
1 min read
Deals

Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health

Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for companion animals, announced that it had acquired substantially all the assets of Assisi Animal Health LLC.

July 18, 2022
·
7 min read
Business

Eagle Pharmaceuticals Appoints Debra M. Hussain as SVP, Head of Commercial

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced the appointment of Debra M. Hussain as Senior Vice President, Head of Commercial.

July 18, 2022
·
15 min read
Fluid Management Devices Market Growth Analysis, 2031 | Product Type | Region | End User | Application

Global fluid management devices market is expected to see a steady rise in demand during the forecast period from 2017 to 2025.

July 18, 2022
·
8 min read